Physician

Erin Marie Deegan, MD

According to 2025 Medicare claims, Erin Deegan, MD (NPI: 1033344239) practices neurology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Dearborn, IN. This provider's primary affiliated billing organization is RIVERHILLS HEALTHCARE INC (NPI: 1205943651; TIN: 311412447) and primary practice location at 41017-3410. Deegan is affiliated with the Healthcare Solutions Network (ACO ID: A3283) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Deegan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 264 traditional Medicare patients, billed 6,066 HCPCS/CPT codes, and received $71,125 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 692 prescription claims across 169 beneficiaries totaling $79,448 in drug costs, led by Carbidopa-Levodopa (Carbidopa/Levodopa). 2018 DME data shows 12 claims. Open Payments data shows 7 records totaling $180. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $18,691 and ending at $71,125. Concurrently, Part D prescription costs have fallen sharply in recent years, from $230,760 to $79,448. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	131	185	$18,691
2016	246	412	$32,603
2017	235	1,135	$40,777
2018	227	819	$31,209
2019	277	7,409	$84,432
2020	282	12,366	$105,224
2021	347	16,503	$154,456
2022	185	8,410	$65,200
2023	56	62	$7,407
2024	264	6,066	$71,125

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	163	656	$230,760
2016	206	1,184	$161,553
2017	229	1,637	$200,663
2018	251	1,423	$154,397
2019	364	1,598	$323,768
2020	403	2,121	$830,444
2021	414	2,309	$1,029,512
2022	349	1,643	$645,304
2023	66	103	$21,846
2024	169	692	$79,448

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$353
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	30	30	$147
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	66	75	$130
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	75	75	$113
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	26	26	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	94	126	$86

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Carbidopa-Levodopa	Carbidopa/Levodopa	151	8,581	$2,997
Gabapentin	Gabapentin	89	2,799	$838
Primidone	Primidone	25	1,168	$520
Escitalopram Oxalate	Escitalopram Oxalate	62	2,462	$463
Levetiracetam	Levetiracetam	13	1,200	$336

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$180	REVANCE THERAPEUTICS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Erin Marie Deegan, MD?

Tedicare shows public-source Medicare data for Erin Marie Deegan, MD (NPI 1033344239), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Erin Marie Deegan, MD have ACO affiliation data?

Erin Marie Deegan, MD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Erin Marie Deegan, MD?

Erin Marie Deegan, MD is linked to RIVERHILLS HEALTHCARE INC (billing NPI 1205943651) in the available physician profile data.

Does Erin Marie Deegan, MD have Open Payments data?

Erin Marie Deegan, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.